These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10092019)

  • 1. Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1.
    Choudhury I; Wang J; Stein S; Rabson A; Leibowitz MJ
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():777-782. PubMed ID: 10092019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression.
    Germinario RJ; Colby-Germinario SP; Acel A; Chandok R; Davison K; Mak J; Kleiman L; Faust E; Wainberg MA
    AIDS Res Hum Retroviruses; 1999 Jun; 15(9):829-36. PubMed ID: 10381171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 replication by a Tat RNA-binding domain peptide analog.
    Choudhury I; Wang J; Rabson AB; Stein S; Pooyan S; Stein S; Leibowitz MJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):104-11. PubMed ID: 9473010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
    Jeyaseelan R; Kurabayashi M; Kedes L
    AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
    Roebuck KA; Rabbi MF; Kagnoff MF
    AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.
    Ivanova G; Reigadas S; Ittig D; Arzumanov A; Andreola ML; Leumann C; Toulmé JJ; Gait MJ
    Oligonucleotides; 2007; 17(1):54-65. PubMed ID: 17461763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
    Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozyme targeting of HIV-1 LTR.
    Ventura M; Wang P; Franck N; Saragosti S
    Biochem Biophys Res Commun; 1994 Sep; 203(2):889-98. PubMed ID: 8093072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
    Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
    Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
    Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus.
    Li CJ; Wang C; Pardee AB
    J Biol Chem; 1994 Mar; 269(10):7051-4. PubMed ID: 8125909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
    Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
    Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
    Kelly GD; Morris CB; Offermann MK
    Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking HIV replication by targeting Tat protein.
    Hamy F; Gelus N; Zeller M; Lazdins JL; Bailly C; Klimkait T
    Chem Biol; 2000 Sep; 7(9):669-76. PubMed ID: 10980447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.